Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution
Open Access
- 1 April 2024
- journal article
- Published by Elsevier BV in European Urology
- Vol. 85 (4), 328-332
- https://doi.org/10.1016/j.eururo.2023.03.020
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM RemodelingCancer Research, 2021
- Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysisNature Communications, 2020
- A Consensus Molecular Classification of Muscle-invasive Bladder CancerEuropean Urology, 2019
- Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsyJCI Insight, 2019
- Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder CancerCell Reports, 2019
- Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II StudyJournal of Clinical Oncology, 2018
- Clonal evolution of chemotherapy-resistant urothelial carcinomaNature Genetics, 2016
- Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatmentAnnals of Oncology, 2016
- Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder CancerEuropean Urology, 2016
- Bladder Cancer Molecular Taxonomy: Summary from a Consensus MeetingBladder Cancer, 2016